Lotus BioScience Ventures
investment firm
About
Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.
- Hong Kong,Hong Kong Island,Hong Kong
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
6
0
Lotus BioScience Ventures has made 6 investments. Their most recent investment was on
Sep 23, 2008, when Humanigen raised $20M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 23, 2008
Humanigen
|
Series D | $20M | Biopharma | — |
|
Oct 19, 2005
Nereus Pharmaceuticals
|
Series D | $42.60M | Biotechnology | — |
|
Aug 11, 2005
Anadys Pharmaceuticals
|
Private Equity（PE） | $71.30M | Biotechnology | — |
|
Mar 16, 2005
Humanigen
|
Series B | $20M | Biopharma | — |
|
Jun 24, 2002
Infinity Pharmaceuticals
|
Series B | $70M | Biopharma | — |
Exits
Lotus BioScience Ventures has had 5 exits. Lotus BioScience Ventures most notable exits include Humanigen , Nereus Pharmaceuticals
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Aug 7, 2017 | Humanigen | IPO | Biopharma | Detail |
| Jan 1, 2012 | Nereus Pharmaceuticals | M&A | Biotechnology | Detail |
| Oct 17, 2011 | Anadys Pharmaceuticals | M&A | Biotechnology | Detail |
| Aug 4, 2009 | Infinity Pharmaceuticals | IPO | Biopharma | Detail |
| Feb 19, 2004 | Dynavax Technologies | IPO | Biopharma | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
